Raffles Medical Group Ltd
Healthcare · EUR · F
Price
€0.627
Cap
€1.16B
Earnings
—
30d Trend
-3.7%
18% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 60×Macro 0.99 (−1%)=59
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder with 5.7% yield
BRAIN47'S ASSESSMENT
I rate Raffles Medical Group Ltd at 59/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 70/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-1.1%
3 MONTHS
-3.2%
12 MONTHS
+0.2%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder with 5.7% yield. low-risk profile and Fundamentals (67) are the primary strengths. I note that technical is the weakest area at 39/100 — this warrants monitoring. Historical volatility is normal at 18%. I classify this as an income position — the 5.7% yield combined with low volatility makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.